PharmaCyte Biotech, Inc.
US ˙ NasdaqCM ˙ US71715X2036

Introduction

This page provides a comprehensive analysis of the known insider trading history of Waggoner Kenneth L.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Waggoner Kenneth L. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:PMCB / PharmaCyte Biotech, Inc. Chairman, CEO, Pres and GC, Director 20,600
US:VELA / VelaTel Global Communications, Inc. EVP Legal, Genl Counsel & Secy, Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Waggoner Kenneth L.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PMCB / PharmaCyte Biotech, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PMCB / PharmaCyte Biotech, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PMCB / PharmaCyte Biotech, Inc. Insider Trades
Insider Sales PMCB / PharmaCyte Biotech, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PMCB / PharmaCyte Biotech, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PMCB / PharmaCyte Biotech, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Waggoner Kenneth L. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2021-08-31 3 PMCB PharmaCyte Biotech, Inc.
Common Stock 		20,600
2013-03-06 2013-01-15 4 VELA VelaTel Global Communications, Inc.
Warrants 		A - Award -787,106 0 -100.00
2013-03-06 2013-01-15 4 VELA VelaTel Global Communications, Inc.
Warrants 		A - Award -1,718,213 0 -100.00
2013-03-06 2013-01-15 4 VELA VelaTel Global Communications, Inc.
Series B Common Stock 		J - Other -220,605 220,605 -50.00 0.00 -221 221
2013-03-06 2013-01-15 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		A - Award 787,106 2,525,124 45.29 0.08 59,741 191,657
2013-03-06 2012-11-29 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		A - Award 1,718,213 1,738,018 8,675.65 0.03 50,000 50,576
2012-12-04 2012-11-29 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 19,805 -50.24 0.55 -11,000 10,893
2012-12-04 2012-11-28 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -3,500 39,805 -8.08 0.50 -1,750 19,902
2012-10-25 2012-10-23 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -16,500 43,305 -27.59 0.05 -825 2,165
2012-10-25 2012-10-23 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -10,000 59,805 -14.33 0.05 -485 2,901
2012-10-25 2012-10-23 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 79,805 -20.04 0.04 -900 3,591
2012-10-25 2012-10-22 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 99,805 -16.69 0.04 -870 4,342
2012-10-25 2012-10-22 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 119,805 -14.31 0.03 -598 3,582
2012-10-25 2012-10-22 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 139,805 -12.52 0.03 -590 4,124
2012-10-25 2012-10-22 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -12,600 159,805 -7.31 0.03 -367 4,650
2012-10-11 2012-10-11 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -7,400 172,405 -4.12 0.03 -215 5,017
2012-10-11 2012-10-11 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 179,805 -10.01 0.03 -566 5,088
2012-10-11 2012-10-09 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 199,805 -9.10 0.02 -480 4,795
2012-10-05 2012-10-05 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -16,000 219,805 -6.79 0.03 -472 6,484
2012-10-05 2012-10-04 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -4,000 235,805 -1.67 0.03 -118 6,956
2012-10-05 2012-10-04 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -10,000 249,805 -3.85 0.03 -285 7,119
2012-10-05 2012-10-04 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -10,000 249,805 -3.85 0.03 -285 7,119
2012-10-05 2012-10-04 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 269,805 -6.90 0.03 -590 7,959
2012-10-05 2012-10-04 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -10,000 289,805 -3.34 0.03 -285 8,259
2012-10-05 2012-10-04 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -20,000 309,805 -6.06 0.03 -560 8,675
2012-10-05 2012-10-02 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -10,000 329,805 -2.94 0.03 -300 9,894
2012-10-03 2012-10-02 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -10,000 329,805 -2.94 0.03 -300 9,894
2012-10-03 2012-09-26 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -15,000 339,805 -4.23 0.02 -368 8,325
2012-09-24 2012-09-20 4 VELA VelaTel Global Communications, Inc.
Common Stock 		S - Sale -5,000 354,805 -1.39 0.04 -200 14,192
2012-09-18 2012-09-14 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -5,000 359,805 -1.37 0.04 -220 15,831
2012-09-18 2012-09-14 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -15,000 360,805 -3.99 0.04 -675 16,236
2012-09-18 2012-08-31 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -4,000 375,805 -1.05 0.07 -276 25,931
2012-09-07 2012-09-06 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -50,000 383,805 -11.53 0.05 -2,500 19,190
2012-09-04 2012-08-30 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale 333,816 433,805 333.85 0.08 28,041 36,440
2012-08-30 2012-08-29 4 VELA VelaTel Global Communications, Inc.
Series A. Common Stock 		S - Sale -1,532 99,989 -1.51 0.09 -138 8,999
2012-08-30 2012-08-28 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -1,908 101,520 -1.84 0.09 -172 9,137
2012-08-09 2012-08-09 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -4,467 103,428 -4.14 0.23 -1,027 23,788
2012-08-09 2012-08-08 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -1,533 107,895 -1.40 0.23 -353 24,816
2012-08-09 2012-08-07 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -1,500 109,428 -1.35 0.25 -375 27,357
2012-07-23 2012-07-18 4 VELA VelaTel Global Communications, Inc.
Series B Common Stock 		J - Other 22,060,607 22,060,607 0.00 22,061 22,061
2012-07-18 2012-07-16 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -5,000 11,092,830 -0.05 0.01 -36 79,868
2012-07-18 2012-07-16 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -245,000 11,097,830 -2.16 0.01 -1,764 79,904
2012-07-11 2012-07-10 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -76,500 11,342,830 -0.67 0.01 -727 107,757
2012-07-11 2012-07-09 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -123,500 11,419,330 -1.07 0.01 -1,173 108,484
2012-07-03 2012-06-29 4 VELA VelaTel Global Communications, Inc.
SERIES A COMMON STOCK 		A - Award 2,215,530 11,542,830 23.75 0.01 25,479 132,743
2012-06-29 2012-06-28 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -102,583 9,327,300 -1.09 0.01 -1,180 107,264
2012-06-29 2012-06-27 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -10,875 9,429,883 -0.12 0.01 -125 108,444
2012-06-04 2012-06-01 4 VELA VelaTel Global Communications, Inc.
SERIES A COMMON STOCK 		A - Award 2,477,247 9,440,758 35.57 0.02 44,343 168,990
2012-05-02 2012-05-02 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		A - Award 1,139,230 6,963,511 19.56 0.02 25,519 155,983
2012-04-04 2012-04-02 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		A - Award 1,243,667 5,824,281 27.15 0.03 36,937 172,981
2012-03-23 2012-03-22 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -500,000 4,580,614 -9.84 0.04 -19,500 178,644
2012-03-23 2012-03-22 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		S - Sale -500,000 5,080,614 -8.96 0.04 -17,500 177,821
2012-03-08 2011-07-15 4 VELA VelaTel Global Communications, Inc.
Option 		A - Award 2,115,384 0 -100.00
2012-03-07 2012-02-29 4 VELA VelaTel Global Communications, Inc.
Series A Common Stock 		A - Award 2,586,291 5,580,614 86.37 0.04 94,400 203,692
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)